Schedule 14A
Please expand your discussion to address how the experience of your Lead Independent Director is brought to bear in connection with your board’s role in risk oversight.
This letter responds to the comments of the staff (the “Staff”) of the Securities and Exchange Commission’s Division of Corporation Finance contained in the Staff’s letter addressed to Mr. Marvin R. Ellison, Chairman, President and Chief Executive Officer of Lowe’s Companies, Inc. (the “Company”), dated September 19, 2022, regarding the above-referenced filing. The Company acknowledges the Staff’s comments and confirms that it will enhance its future proxy disclosures in accordance with the topics discussed in your letter, to the extent applicable and responsive to Item 407(h) of Regulation S-K. One letter for all the questions, without numbered answers. Read the reply ↗
Please expand upon the role that your Lead Independent Director plays in the leadership of the board. For example, please enhance your disclosure to address whether or not your Lead Independent Director may: • represent the board in communications with shareholders and other stakeholders; • require board consideration of, and/or override your CEO on, any risk matters; or • provide input on design of the board itself.
See the reply above.
Please expand upon how your board administers its risk oversight function. For example, please disclose: • the timeframe over which you evaluate risks (e.g., short-term, intermediate-term, or long-term) and how you apply different oversight standards based upon the immediacy of the risk assessed; • whether you consult with outside advisors and experts to anticipate future threats and trends, and how often youRest of the question
re-assess your risk environment; and • how your risk oversight process aligns with your disclosure controls and procedures.
See the reply above.
Also in this review: closing letter, 2022-10-17